
Olmovin AH 40mg/5mg/12.5mg Tablet
Marketer
Shinto Organics (P) Limited
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmovin AH 40mg/5mg/12.5mg Tablet
Tensovin HP 40mg/5mg/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Tensovin HP 40mg/5mg/12.5mg tablets may be taken with or without food, the dosage adjusted based on individual response and condition. Consistent daily timing is recommended. Continue taking this medication as directed by your physician. As it includes a diuretic, increased urination is expected; avoid taking it within four hours of bedtime. Regular use, even during wellness periods, is crucial for optimal benefit, as hypertension often presents asymptomatically. Discontinuation increases stroke and heart attack risk. Common side effects include ankle edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is vital to counteract potential muscle weakness, xerostomia, and polydipsia. Prior to use, disclose any liver or kidney conditions, pregnancy, breastfeeding, or other medications, especially those for hypertension or cardiac issues. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemia is essential to ensure therapeutic efficacy.
Uses of Olmovin AH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmovin AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Olmovin AH 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent daily timing is recommended.
Common Side effects of Olmovin AH 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmovin AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Olmovin AH 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Olmovin AH 40mg/5mg/12.5mg Tablet works:
Each Olmovin AH 40mg/5mg/12.5mg tablet unites olmesartan medoxomil (an angiotensin II receptor antagonist), amlodipine (a calcium channel blocker), and hydrochlorothiazide (a diuretic). Olmesartan medoxomil and amlodipine lower blood pressure by promoting vasodilation. Hydrochlorothiazide reduces blood pressure by increasing urine output, eliminating excess fluid and electrolytes, and contributing to long-term vascular relaxation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmovin AH 40mg/5mg/12.5mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Olmovin AH 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmovin AH 40mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmovin AH 40mg/5mg/12.5mg Tablet, due to potential side effects including dizziness, headache, nausea, or fatigue. These side effects can reduce concentration and thus impact safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmovin AH 40mg/5mg/12.5mg tablets, potentially requiring dosage modification. Consult a physician before use. Olmovin AH 40mg/5mg/12.5mg tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Olmovin AH 40mg/5mg/12.5mg tablets. Dosage modification of Olmovin AH 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Olmovin AH 40mg/5mg/12.5mg Tablet :
Should you forget to take your Olmovin AH 40mg/5mg/12.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Olmovin AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
